Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kita DB"'
Autor:
Short KM; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA. Electronic address: kshort@verseon.com., Estiarte MA; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Pham SM; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Williams DC; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Igoudin L; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Dash S; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Sandoval N; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Datta A; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA., Pozzi N; Department of Biochemistry and Molecular Biology, Edward A. Doisy Research Center, Saint Louis University School of Medicine, 1100 South Grand Blvd., St. Louis, MO, 63104, USA., Di Cera E; Department of Biochemistry and Molecular Biology, Edward A. Doisy Research Center, Saint Louis University School of Medicine, 1100 South Grand Blvd., St. Louis, MO, 63104, USA., Kita DB; Verseon, 47071 Bayside Parkway, Fremont, CA, 94538, USA.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Jan 15; Vol. 246, pp. 114855. Date of Electronic Publication: 2022 Oct 27.
Autor:
Sivaraja M; Verseon Corporation, Fremont, CA, United States of America. Electronic address: msivaraja@verseon.com., Clemens DM; Verseon Corporation, Fremont, CA, United States of America., Sizikov S; Verseon Corporation, Fremont, CA, United States of America., Dash S; Verseon Corporation, Fremont, CA, United States of America., Xu C; Verseon Corporation, Fremont, CA, United States of America., Rienzo M; Verseon Corporation, Fremont, CA, United States of America., Yang B; Verseon Corporation, Fremont, CA, United States of America., Ryan M; Verseon Corporation, Fremont, CA, United States of America., Chattopadhyay M; Verseon Corporation, Fremont, CA, United States of America., Igoudin L; Verseon Corporation, Fremont, CA, United States of America., Chang SS; Verseon Corporation, Fremont, CA, United States of America., Keutzer S; Verseon Corporation, Fremont, CA, United States of America., Zalicki P; Verseon Corporation, Fremont, CA, United States of America., Estiarte MA; Verseon Corporation, Fremont, CA, United States of America., Shiau TP; Verseon Corporation, Fremont, CA, United States of America., Short KM; Verseon Corporation, Fremont, CA, United States of America., Williams DC; Verseon Corporation, Fremont, CA, United States of America., Datta A; Verseon Corporation, Fremont, CA, United States of America., Pozzi N; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States of America., Di Cera E; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States of America., Gibson CM; TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States of America., Fox KAA; Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Kita DB; Verseon Corporation, Fremont, CA, United States of America.
Publikováno v:
Thrombosis research [Thromb Res] 2020 Jun; Vol. 190, pp. 112-121. Date of Electronic Publication: 2020 Apr 19.
Autor:
Sivaraja M; Verseon Corporation, Fremont, California, United States of America., Pozzi N; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America., Rienzo M; Verseon Corporation, Fremont, California, United States of America., Lin K; Verseon Corporation, Fremont, California, United States of America., Shiau TP; Verseon Corporation, Fremont, California, United States of America., Clemens DM; Verseon Corporation, Fremont, California, United States of America., Igoudin L; Verseon Corporation, Fremont, California, United States of America., Zalicki P; Verseon Corporation, Fremont, California, United States of America., Chang SS; Verseon Corporation, Fremont, California, United States of America., Estiarte MA; Verseon Corporation, Fremont, California, United States of America., Short KM; Verseon Corporation, Fremont, California, United States of America., Williams DC; Verseon Corporation, Fremont, California, United States of America., Datta A; Verseon Corporation, Fremont, California, United States of America., Di Cera E; Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America., Kita DB; Verseon Corporation, Fremont, California, United States of America.
Publikováno v:
PloS one [PLoS One] 2018 Aug 02; Vol. 13 (8), pp. e0201377. Date of Electronic Publication: 2018 Aug 02 (Print Publication: 2018).